Human Adipose-Derived Mesenchymal Stem Cells Promote Liver Regeneration

Area of Science:

• Regenerative Medicine
• Hepatology
• Stem Cell Therapy

Background:

• Liver regeneration (LR) is critical for patients with acute liver failure, post-transplant, or major liver resection.
• Human adipose-derived mesenchymal stem cells (HADMSC) are an accessible cell source for regenerative medicine.
• Investigating HADMSC's efficacy in promoting LR is essential for clinical applications.

Purpose of the Study:

• To evaluate the therapeutic potential of HADMSC in accelerating liver regeneration.
• To test the hypothesis that HADMSC administration promotes LR in a murine model.

Main Methods:

• Acute liver failure (ALF) was induced in mice using carbon tetrachloride (CCl4).
• Mice received HADMSC treatment before CCl4 administration.
• Liver injury was assessed via serum ALT, IL-6 levels, and histopathology, including PCNA staining for cell proliferation.

Main Results:

• HADMSC treatment significantly attenuated liver injury, evidenced by reduced serum ALT and IL-6 levels.
• Histological analysis showed a decrease in liver damage and an increase in PCNA-positive cells in HADMSC-treated mice.
• Improved survival rates were observed in animals treated with HADMSC compared to controls.

Conclusions:

• HADMSC treatment demonstrates a protective effect against CCl4-induced liver injury.
• HADMSC administration promotes liver regeneration and enhances survival in a murine model.
• HADMSC represent a promising therapeutic strategy for enhancing liver regeneration.